Page last updated: 2024-11-04

sulfamethoxazole and Abnormalities, Congenital

sulfamethoxazole has been researched along with Abnormalities, Congenital in 2 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaffe, P1
Liberman, MM1
McFadyen, I1
Valman, HB1
Nguyen, BT1
Stadtsbaeder, S1

Other Studies

2 other studies available for sulfamethoxazole and Abnormalities, Congenital

ArticleYear
Letter: Incidence of congenital limb-reduction deformities.
    Lancet (London, England), 1975, Mar-01, Volume: 1, Issue:7905

    Topics: Abnormalities, Drug-Induced; Arm; Benzyl Compounds; Birth Weight; Congenital Abnormalities; England;

1975
Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).
    British journal of pharmacology, 1985, Volume: 85, Issue:3

    Topics: Animals; Antibodies; Birth Weight; Congenital Abnormalities; Delivery, Obstetric; Drug Combinations;

1985